|
⚲
|
| Nile Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001133869 |
| Sale | 2009-07-07 ($3.0 M Offered, $2.3 M Sold) |
| Fund | |
| Phone | 4158757880 |
| Address | 115 Sansome Street San Francisco, 94104 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Pedro Granadillo | |
| David Tanen | |
| Gregory Schafer | |
| Joshua Kazam | |
| Peter Kash | |
| Paul Mieyal PhD | |
| Daron Evans |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Sagard Healthcare Royalty Partners ICAV
✚
|
0.0 | |
|
SaiOx Inc
✚
|
0.0 | |
|
BMO Harris Investment Management Inc
✚
|
0.0 | |
|
B Riley Principal Investments LLC
✚
|
0.0 | |
|
First Bancorp, Inc /ME/
✚
|
0.0 | |
|
Global X (AUS) Pty Ltd
✚
|
0.0 | |
|
RTW Innovation Master Fund Ltd.
✚
|
0.0 | |
|
SalesforceCom Inc
✚
|
0.0 | |
|
Coefficient Capital Fund I, LP
✚
|
0.0 | |
|
Safer Made, LP
✚
|
0.0 |